Global Strategic Investment Solutions’s Novo Nordisk NVO Stock Holding History

Global Strategic Investment Solutions’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$411K	Sell	8,569 -967	-10%	-$41.5K	0.04%	112
2026 Q1	$351K	Sell	9,536 -3,844	-29%	-$182K	0.03%	116
2025 Q4	$681K	Hold	13,380	–	–	0.07%	91
2025 Q3	$742K	Hold	13,380	–	–	0.07%	85
2025 Q2	$923K	Sell	13,380 -6	-0%	-$408	0.1%	76
2025 Q1	$930K	Hold	13,386	–	–	0.11%	71
2024 Q4	$1.15M	Hold	13,386	–	–	0.13%	70
2024 Q3	$1.59M	Hold	13,386	–	–	0.19%	56
2024 Q2	$1.91M	Hold	13,386	–	–	0.23%	52
2024 Q1	$1.72M	Hold	13,386	–	–	0.2%	54
2023 Q4	$1.38M	Sell	13,386 -12	-0.1%	-$1.19K	0.17%	59
2023 Q3	$1.22M	Sell	13,398 -10	-0.1%	-$881	0.16%	63
2023 Q2	$1.08M	Hold	13,408	–	–	0.14%	63
2023 Q1	$1.07M	Hold	13,408	–	–	0.15%	60
2022 Q4	$907K	Buy	13,408 +28	+0.2%	+$1.64K	0.06%	64
2022 Q3	$667K	Buy	13,380 +7,000	+110%	+$375K	0.03%	77
2022 Q2	$355K	Sell	6,380 -7,000	-52%	-$388K	0.03%	89
2022 Q1	$743K	Hold	13,380	–	–	0.05%	69
2021 Q4	$749K	Hold	13,380	–	–	0.12%	61
2021 Q3	$642K	Hold	13,380	–	–	0.11%	63
2021 Q2	$560K	Hold	13,380	–	–	0.09%	70
2021 Q1	$451K	Hold	13,380	–	–	0.08%	88
2020 Q4	$467K	Hold	13,380	–	–	0.11%	67
2020 Q3	$464K	Hold	13,380	–	–	0.12%	66
2020 Q2	$438K	Hold	13,380	–	–	0.12%	61
2020 Q1	$403K	Hold	13,380	–	–	0.15%	50
2019 Q4	$387K	Hold	13,380	–	–	0.14%	44
2019 Q3	$346K	Buy	+13,380	New	+$338K	0.14%	47
2019 Q2	–	Sell	-13,380	Closed	-$350K	–	60
2019 Q1	$350K	Hold	13,380	–	–	0.19%	38
2018 Q4	$308K	Buy	+13,380	New	+$297K	0.26%	37

Other funds holding NVO

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

EHC

Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SRIM

Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return

Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

Global Strategic Investment Solutions's NVO Position: Q2 2026 in Review

Global Strategic Investment Solutions reduced its Novo Nordisk (NVO) stake by 10% in Q2 2026, selling an estimated $41.5K and leaving 8,569 shares worth $411K. The position accounts for 0.04% of the portfolio, ranked #112.

Global Strategic Investment Solutions first reported a position in NVO in Q4 2018 and has held it in 30 quarters since. The position peaked at $1.91M in Q2 2024. 819 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Global Strategic Investment Solutions held 8,569 shares of Novo Nordisk worth $411K as of Q2 2026.
Global Strategic Investment Solutions sold 967 Novo Nordisk shares in Q2 2026, an estimated $41.5K.
Novo Nordisk made up 0.04% of Global Strategic Investment Solutions's portfolio in Q2 2026, its #112 holding.
Global Strategic Investment Solutions first reported a position in Novo Nordisk in Q4 2018 and has held it in 30 quarters since.
Global Strategic Investment Solutions's Novo Nordisk position peaked at $1.91M in Q2 2024.
819 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Global Strategic Investment Solutions's 13F filing for Q2 2026, filed 7 Aug 2026.